Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
Journal for immunotherapy of cancer(2023)
摘要
NCT03162731.
更多查看译文
关键词
Nivolumab, Ipilimumab, Immunotherapy, Radiotherapy, Head and Neck Neoplasms
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要